Lantern Pharma (LTRN) Reports Q1 Loss of $0.51
Tweet
Share
E-mailGet Alerts LTRN Hot Sheet
Join SI Premium – FREE
Lantern Pharma (NASDAQ: LTRN) reported Q1 EPS of ($0.51).
For earnings history and earnings-related data on Lantern Pharma (LTRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- SPS Commerce hires Morgan Stanley to explore sale amid activist push - Reuters
- CVG to join Russell 2000 and Russell 3000 indexes June 26
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
